BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37701444)

  • 1. Divergent CD4
    Khelfa M; Leclerc M; Kerbrat S; Boudjemai YNS; Benchouaia M; Neyrinck-Leglantier D; Cagnet L; Berradhia L; Tamagne M; Croisille L; Pirenne F; Maury S; Vingert B
    Front Immunol; 2023; 14():1165973. PubMed ID: 37701444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant immune response to HLA-B57/B58 molecules after platelet transfusion.
    Coombs J; Ben Hassen L; Leclerc M; Tamagne M; Pannetier L; Khelfa M; Delorme A; Bocquet T; Maury S; Pirenne F; Ansart-Pirenne H; Vingert B
    Transfusion; 2020 Dec; 60(12):2807-2814. PubMed ID: 33037638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-blood phenotyping to assess alloimmunization status in transfused sickle cell disease patients.
    Tamagne M; Pakdaman S; Bartolucci P; Habibi A; Galactéros F; Pirenne F; Vingert B
    Blood Adv; 2021 Mar; 5(5):1278-1282. PubMed ID: 33651102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet transfusion refractoriness due to HLA alloimmunization: Evolving paradigms in mechanisms and management.
    Panch SR; Guo L; Vassallo R
    Blood Rev; 2023 Nov; 62():101135. PubMed ID: 37805287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemin controls T cell polarization in sickle cell alloimmunization.
    Zhong H; Bao W; Friedman D; Yazdanbakhsh K
    J Immunol; 2014 Jul; 193(1):102-10. PubMed ID: 24879794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
    Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
    Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of Alloimmunization.
    Molina-Aguilar R; Gómez-Ruiz S; Vela-Ojeda J; Montiel-Cervantes LA; Reyes-Maldonado E
    Transfus Med Hemother; 2020 Apr; 47(2):152-159. PubMed ID: 32355475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical aspects of platelet transfusions.
    Murphy MF; Waters AH
    Blood Coagul Fibrinolysis; 1991 Apr; 2(2):389-96. PubMed ID: 1893071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloimmunization following platelet transfusions in patients with acute nonlymphocytic leukemia.
    Nozaki H; Shimizu M; Komatsuda M; Watanabe K; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1986 Aug; 11(3):201-4. PubMed ID: 3475819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Regulation of sickle Cell Alloimmunization.
    Yazdanbakhsh K; Shaz BH; Hillyer CD
    ISBT Sci Ser; 2017 Feb; 12(1):248-253. PubMed ID: 28261322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers involved in evaluation of platelets function in South-Eastern Romanian patients with hematological malignancies subtypes.
    Matei E; Aschie M; Mitroi AF; Ghinea MM; Gheorghe E; Petcu L; Dobrin N; Chisoi A; Mihaela M
    Medicine (Baltimore); 2021 May; 100(20):e25944. PubMed ID: 34011073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion.
    Nickel RS; Horan JT; Fasano RM; Meyer E; Josephson CD; Winkler AM; Yee ME; Kean LS; Hendrickson JE
    Am J Hematol; 2015 Dec; 90(12):1135-41. PubMed ID: 26361243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients.
    Duquesnoy RJ; Filip DJ; Rodey GE; Rimm AA; Aster RH
    Am J Hematol; 1977; 2(3):219-26. PubMed ID: 596366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized.
    Dutcher JP; Schiffer CA; Aisner J; Wiernik PH
    Blood; 1981 Nov; 58(5):1007-11. PubMed ID: 6794674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloimmunization to platelet-specific antigens on glycoproteins IIb-IIIa and Ib/IX in multiply transfused thrombocytopenic patients.
    Kickler T; Kennedy SD; Braine HG
    Transfusion; 1990 Sep; 30(7):622-5. PubMed ID: 2402776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion-induced platelet antibodies and regulatory T cells in multiply transfused patients.
    Song T; Zhang Y; Huang J; Liu Z
    J Clin Lab Anal; 2021 Jul; 35(7):e23864. PubMed ID: 34125970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloimmunization to platelets in heavily transfused patients with sickle cell disease.
    Friedman DF; Lukas MB; Jawad A; Larson PJ; Ohene-Frempong K; Manno CS
    Blood; 1996 Oct; 88(8):3216-22. PubMed ID: 8874223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.
    Williams P; Basu S; Garcia-Manero G; Hourigan CS; Oetjen KA; Cortes JE; Ravandi F; Jabbour EJ; Al-Hamal Z; Konopleva M; Ning J; Xiao L; Hidalgo Lopez J; Kornblau SM; Andreeff M; Flores W; Bueso-Ramos C; Blando J; Galera P; Calvo KR; Al-Atrash G; Allison JP; Kantarjian HM; Sharma P; Daver NG
    Cancer; 2019 May; 125(9):1470-1481. PubMed ID: 30500073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of RhD-positive red blood cell administration is associated with D-alloimmunization in injured patients.
    Yazer MH; Spinella PC; Sperry J; Triulzi DJ; Leeper C
    Transfusion; 2023 May; 63 Suppl 3():S54-S59. PubMed ID: 37067374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.